Mineralys Therapeutics, Inc. - Common Stock (NQ:MLYS)
Price and Volume
Detailed Quote| Volume | 1,234,776 |
| Open | 29.71 |
| Bid (Size) | 30.30 (200) |
| Ask (Size) | 31.10 (500) |
| Prev. Close | 29.12 |
| Today's Range | 29.27 - 31.11 |
| 52wk Range | 12.59 - 47.65 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Mineralys (MLYS) Q1 2026 Earnings Transcript ↗
May 06, 2026
Earnings Scheduled For November 10, 2025 ↗
November 10, 2025
Mineralys (MLYS) Q4 2025 Earnings Call Transcript ↗
March 12, 2026
Uncovering Potential: Mineralys Therapeutics's Earnings Preview ↗
November 07, 2025
It's a Small World: 3 Stocks Leading the Sudden Rebound in Small Caps ↗
September 16, 2025
Here are the top movers in Tuesday's session. ↗
September 02, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
September 02, 2025
There are notable gap-ups and gap-downs in today's session. ↗
September 02, 2025
Nasdaq Down 1%; Signet Jewelers Earnings Top Views ↗
September 02, 2025
Frequently Asked Questions
Is Mineralys Therapeutics, Inc. - Common Stock publicly traded?
Yes, Mineralys Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Mineralys Therapeutics, Inc. - Common Stock trade on?
Mineralys Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Mineralys Therapeutics, Inc. - Common Stock?
The ticker symbol for Mineralys Therapeutics, Inc. - Common Stock is MLYS on the Nasdaq Stock Market
What is the current price of Mineralys Therapeutics, Inc. - Common Stock?
The current price of Mineralys Therapeutics, Inc. - Common Stock is 30.46
When was Mineralys Therapeutics, Inc. - Common Stock last traded?
The last trade of Mineralys Therapeutics, Inc. - Common Stock was at 07/07/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.